T John Cavan

Chief Financial Officer at Hepion Pharmaceuticals Inc. (HEPA), 2021-05-20
Vp & Chief Accounting Officer at Aegerion Pharmaceuticals Inc. (AEGR), 2010-10-22

Insider Trading: Purchases See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
HEPA	$2.00	10,000	$20,000.00	14,800	2021-02-18	Filing
HEPA	$1.62	4,500	$7,290.00	4,800	2020-11-25	Filing
CTRV	$0.65	20,000	$13,000.00	20,000	2017-06-20	Filing